Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
Videos
Keck School of Medicine of USC
Optimizing Treatment of AFib: What Drugs Are Recommended in ACA/AHA/HRS Guidelines? When to Perform RF Catheter Ablation?
FEATURING
Anil Bhandari
- 870 views
- February 12, 2021
- 5
Keck School of Medicine of USC
Stroke Prevention in AFib: Should You Perform LAA Closure or Prescribe Warfarin?
FEATURING
Ivan Ho
- 208 views
- February 12, 2021
Keck School of Medicine of USC
Takotsubo Syndrome: What Diagnostic Criteria Are Available? Which Drugs to Use and Which Should Be Avoided?
FEATURING
Helga Van Herle
- 187 views
- February 11, 2021
- 4
Keck School of Medicine of USC
Role of Lipoprotein(a) in Coronary Disease: What CV Risks Can you Expect? How to Manage the Condition?
FEATURING
Steven Nissen
- 483 views
- January 5, 2021
- 5
Keck School of Medicine of USC
Newer Therapies in Management of Chronic Heart Failure: Roles of SGLT2 Inhibitors and Vericiguat
FEATURING
Kruti Pandya
- 281 views
- December 28, 2020
Keck School of Medicine of USC
Can Diets Help Treat ADPKD?
FEATURING
Thomas Weimbs
- 187 views
- December 18, 2020
- 2
Keck School of Medicine of USC
Amyloidosis & Kidney Disease: What Are the New Advances in Diagnosis & Management?
FEATURING
Miroslaw Smogorzewski
- 327 views
- December 17, 2020
- 1
Keck School of Medicine of USC
31 y/o With IgG4-Related Kidney Disease: How to Treat IgG4-RKD With Systemic Epstein-Barr Virus Infection?
FEATURING
Yan Zhong
- 157 views
- December 17, 2020
- 2
Keck School of Medicine of USC
TAME-PKD 2020 Trial Review on Metformin in ADPKD: How Tolerable and Safe Is It?
FEATURING
Ronald D. Perrone
- 257 views
- December 17, 2020
Keck School of Medicine of USC
Polycystic Kidney Disease: What Are the New Signaling Pathways and Possible Therapeutic Targets?
FEATURING
Michael Kaplan
- 285 views
- December 17, 2020
- 3
Keck School of Medicine of USC
2020 Update on ADPKD Treatment: What Are the Novel Drug Candidates, and Why Are They Promising?
FEATURING
Kenneth R. Hallows
- 576 views
- December 17, 2020
- 3
Keck School of Medicine of USC
Polycystic Kidney Disease: What Is the Efficacy of Tolvaptan, and How Does It Compare to Other Renal Protective Therapies?
FEATURING
Neera Dahl
- 649 views
- December 17, 2020
- 3
Keck School of Medicine of USC
USC 2020 Update on Advanced Thyroid Cancer: Do Targeted Therapies Lead to Improved OS Without Affecting Quality of Life?
FEATURING
Naifa Busaidy
- 148 views
- December 7, 2020
- 1
Keck School of Medicine of USC
Thyroid Surgery Management: What Are the Indications, and How to Do Preoperative Evaluation?
FEATURING
Daniel Kwon
- 251 views
- December 1, 2020
Keck School of Medicine of USC
Thyroid & Immunotherapy: What Are the Effects, and How Do We Manage Thyroiditis?
FEATURING
Melissa Lechner
- 663 views
- December 1, 2020
- 5
Keck School of Medicine of USC
Update on Thyroid Eye Disease: What Are the Novel Treatment Options and Therapeutic Considerations?
FEATURING
Chrysoula Dosiou
- 281 views
- December 1, 2020
Keck School of Medicine of USC
Thyroid Disease in the Time of COVID-19: What Are the Management Recommendations?
FEATURING
Trevor E. Angell
- 239 views
- December 1, 2020
- 1
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
DMARDS Biologic in RA: What Are Safety Issues and Concerns? What Are the Malignancy, and Immune Disease Risks Induced by Biologics?
FEATURING
Glenn Ehresmann
- 291 views
- November 11, 2020
- 3
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
RA and Biologic Therapies Update: Where Do Products Fit on the RA Spectrum of Treatment? What Are Specifics on TNF Inhibitors, Il-1, Il-6 Receptor Blockers and CD20 Antigens on Lymphocytes?
FEATURING
Glenn Ehresmann
- 466 views
- November 11, 2020
- 4
